Annual EBITDA
-$24.10 M
-$9.91 M-69.80%
31 December 2023
Summary:
Trinity Biotech annual earnings before interest, taxes, depreciation & amortization is currently -$24.10 million, with the most recent change of -$9.91 million (-69.80%) on 31 December 2023. During the last 3 years, it has fallen by -$26.08 million (-1317.64%). TRIB annual EBITDA is now -137.26% below its all-time high of $64.67 million, reached on 31 December 2010.TRIB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.11 M
+$201.00 K+15.31%
30 September 2024
Summary:
Trinity Biotech quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.11 million, with the most recent change of +$201.00 thousand (+15.31%) on 30 September 2024. Over the past year, it has increased by +$2.77 million (+71.35%). TRIB quarterly EBITDA is now -102.19% below its all-time high of $50.84 million, reached on 30 June 2010.TRIB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.37 M
+$2.77 M+24.86%
30 September 2024
Summary:
Trinity Biotech TTM earnings before interest, taxes, depreciation & amortization is currently -$8.37 million, with the most recent change of +$2.77 million (+24.86%) on 30 September 2024. Over the past year, it has increased by +$33.69 million (+80.10%). TRIB TTM EBITDA is now -113.39% below its all-time high of $62.51 million, reached on 31 March 2011.TRIB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.8% | +71.3% | +80.1% |
| 3 y3 years | -1317.6% | -129.8% | -136.2% |
| 5 y5 years | -72.3% | -177.4% | +56.4% |
TRIB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -369.1% | at low | -129.8% | +94.6% | -252.5% | +81.5% |
| 5 y | 5 years | -369.1% | at low | -112.2% | +96.0% | -252.5% | +81.5% |
| alltime | all time | -137.3% | +66.3% | -102.2% | +99.4% | -113.4% | +95.0% |
Trinity Biotech EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.11 M(-15.3%) | -$8.37 M(-24.9%) |
| June 2024 | - | -$1.31 M(-42.8%) | -$11.14 M(-53.8%) |
| Mar 2024 | - | -$2.29 M(-37.2%) | -$24.14 M(-3.5%) |
| Dec 2023 | -$24.10 M(+69.8%) | -$3.65 M(-5.9%) | -$25.00 M(-40.6%) |
| Sept 2023 | - | -$3.88 M(-72.9%) | -$42.06 M(-7.0%) |
| June 2023 | - | -$14.31 M(+352.3%) | -$45.24 M(+39.1%) |
| Mar 2023 | - | -$3.16 M(-84.7%) | -$32.52 M(+9.5%) |
| Dec 2022 | -$14.19 M(-258.5%) | -$20.71 M(+193.5%) | -$29.70 M(+140.2%) |
| Sept 2022 | - | -$7.06 M(+344.2%) | -$12.37 M(+688.1%) |
| June 2022 | - | -$1.59 M(+370.1%) | -$1.57 M(-175.7%) |
| Mar 2022 | - | -$338.00 K(-90.0%) | $2.07 M(-62.2%) |
| Dec 2021 | $8.95 M(+352.5%) | -$3.38 M(-190.4%) | $5.49 M(-254.9%) |
| Sept 2021 | - | $3.74 M(+82.1%) | -$3.54 M(-296.2%) |
| June 2021 | - | $2.05 M(-33.3%) | $1.81 M(+605.5%) |
| Mar 2021 | - | $3.08 M(-124.8%) | $256.00 K(-123.3%) |
| Dec 2020 | $1.98 M(-110.7%) | -$12.41 M(-236.6%) | -$1.10 M(-93.3%) |
| Sept 2020 | - | $9.09 M(+1706.8%) | -$16.33 M(-31.9%) |
| June 2020 | - | $503.00 K(-70.8%) | -$23.98 M(+3.6%) |
| Mar 2020 | - | $1.72 M(-106.2%) | -$23.15 M(-1.1%) |
| Dec 2019 | -$18.52 M(+32.5%) | -$27.65 M(-2023.9%) | -$23.41 M(+21.9%) |
| Sept 2019 | - | $1.44 M(+7.4%) | -$19.21 M(-0.1%) |
| June 2019 | - | $1.34 M(-8.4%) | -$19.24 M(+3.1%) |
| Mar 2019 | - | $1.46 M(-106.2%) | -$18.65 M(+3.0%) |
| Dec 2018 | -$13.98 M(-52.2%) | -$23.45 M(-1761.7%) | -$18.10 M(-47.3%) |
| Sept 2018 | - | $1.41 M(-26.6%) | -$34.38 M(+1.0%) |
| June 2018 | - | $1.92 M(-4.4%) | -$34.05 M(+0.3%) |
| Mar 2018 | - | $2.01 M(-105.1%) | -$33.94 M(-1.5%) |
| Dec 2017 | -$29.27 M(-4.2%) | -$39.72 M(-2382.9%) | -$34.47 M(-668.1%) |
| Sept 2017 | - | $1.74 M(-14.2%) | $6.07 M(-16.4%) |
| June 2017 | - | $2.03 M(+36.6%) | $7.26 M(-7.1%) |
| Mar 2017 | - | $1.49 M(+82.4%) | $7.81 M(-6.7%) |
| Dec 2016 | -$30.57 M(-193.7%) | $814.00 K(-72.2%) | $8.37 M(-29.0%) |
| Sept 2016 | - | $2.93 M(+13.6%) | $11.79 M(-47.7%) |
| June 2016 | - | $2.58 M(+26.1%) | $22.55 M(-6.2%) |
| Mar 2016 | - | $2.04 M(-51.7%) | $24.05 M(-8.7%) |
| Dec 2015 | $32.64 M(+63.0%) | $4.24 M(-69.0%) | $26.34 M(+10.7%) |
| Sept 2015 | - | $13.69 M(+235.4%) | $23.80 M(+61.2%) |
| June 2015 | - | $4.08 M(-5.9%) | $14.77 M(-3.6%) |
| Mar 2015 | - | $4.34 M(+155.1%) | $15.32 M(-1.4%) |
| Dec 2014 | $20.03 M(+44.5%) | $1.70 M(-63.5%) | $15.53 M(+46.7%) |
| Sept 2014 | - | $4.65 M(+0.4%) | $10.59 M(-3.3%) |
| June 2014 | - | $4.63 M(+1.9%) | $10.95 M(+4.8%) |
| Mar 2014 | - | $4.55 M(-240.2%) | $10.45 M(+1.7%) |
| Dec 2013 | $13.86 M(-37.8%) | -$3.24 M(-164.7%) | $10.27 M(-44.3%) |
| Sept 2013 | - | $5.01 M(+21.3%) | $18.43 M(+0.4%) |
| June 2013 | - | $4.13 M(-5.4%) | $18.37 M(-4.0%) |
| Mar 2013 | - | $4.37 M(-11.2%) | $19.14 M(-1.6%) |
| Dec 2012 | $22.28 M(+7.1%) | $4.92 M(-0.5%) | $19.45 M(+1.1%) |
| Sept 2012 | - | $4.95 M(+0.9%) | $19.23 M(+1.6%) |
| June 2012 | - | $4.90 M(+4.8%) | $18.93 M(+2.1%) |
| Mar 2012 | - | $4.68 M(-0.5%) | $18.55 M(+1.9%) |
| Dec 2011 | $20.80 M(-67.8%) | $4.70 M(+1.2%) | $18.21 M(+3.2%) |
| Sept 2011 | - | $4.65 M(+2.9%) | $17.65 M(+9.0%) |
| June 2011 | - | $4.52 M(+4.1%) | $16.19 M(-74.1%) |
| Mar 2011 | - | $4.34 M(+4.9%) | $62.51 M(+1.1%) |
| Dec 2010 | $64.67 M(+262.3%) | $4.14 M(+29.5%) | $61.85 M(+1.1%) |
| Sept 2010 | - | $3.19 M(-93.7%) | $61.21 M(-0.9%) |
| June 2010 | - | $50.84 M(+1279.2%) | $61.74 M(+318.6%) |
| Mar 2010 | - | $3.69 M(+5.6%) | $14.75 M(+4.6%) |
| Dec 2009 | $17.85 M(-125.0%) | $3.49 M(-6.5%) | $14.11 M(-118.8%) |
| Sept 2009 | - | $3.73 M(-2.9%) | -$75.00 M(-2.2%) |
| June 2009 | - | $3.84 M(+26.3%) | -$76.70 M(-1.9%) |
| Mar 2009 | - | $3.04 M(-103.6%) | -$78.20 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | -$71.47 M(+237.8%) | -$85.62 M(-4317.5%) | -$79.45 M(-52.2%) |
| Sept 2008 | - | $2.03 M(-13.3%) | -$166.37 M(+24.5%) |
| June 2008 | - | $2.34 M(+30.8%) | -$133.67 M(+1.0%) |
| Mar 2008 | - | $1.79 M(-101.0%) | -$132.31 M(+1.2%) |
| Dec 2007 | -$21.16 M(-352.9%) | -$172.53 M(-596.7%) | -$130.79 M(-405.1%) |
| Sept 2007 | - | $34.73 M(+839.3%) | $42.87 M(+286.6%) |
| June 2007 | - | $3.70 M(+11.7%) | $11.09 M(+202.3%) |
| Mar 2007 | - | $3.31 M(+195.5%) | $3.67 M(+88.9%) |
| Dec 2006 | $8.36 M(-23.0%) | $1.12 M(-62.1%) | $1.94 M(-39.5%) |
| Sept 2006 | - | $2.96 M(-179.5%) | $3.21 M(+53.5%) |
| June 2006 | - | -$3.72 M(-334.7%) | $2.09 M(-70.8%) |
| Mar 2006 | - | $1.59 M(-33.6%) | $7.15 M(-3.8%) |
| Dec 2005 | $10.86 M(+25.8%) | $2.39 M(+29.7%) | $7.43 M(+7.0%) |
| Sept 2005 | - | $1.84 M(+37.9%) | $6.94 M(-9.5%) |
| June 2005 | - | $1.33 M(-28.7%) | $7.67 M(-8.6%) |
| Mar 2005 | - | $1.87 M(-1.4%) | $8.40 M(+9.8%) |
| Dec 2004 | $8.63 M(-27.4%) | $1.90 M(-26.1%) | $7.65 M(-11.2%) |
| Sept 2004 | - | $2.57 M(+24.9%) | $8.61 M(-1.5%) |
| June 2004 | - | $2.06 M(+83.3%) | $8.73 M(-5.4%) |
| Mar 2004 | - | $1.12 M(-60.7%) | $9.23 M(-15.4%) |
| Dec 2003 | $11.89 M(+18.6%) | $2.86 M(+5.9%) | $10.91 M(+12.4%) |
| Sept 2003 | - | $2.70 M(+5.7%) | $9.71 M(+4.5%) |
| June 2003 | - | $2.55 M(-9.0%) | $9.29 M(+3.5%) |
| Mar 2003 | - | $2.80 M(+69.3%) | $8.98 M(+7.9%) |
| Dec 2002 | $10.03 M(+15.4%) | $1.66 M(-27.3%) | $8.32 M(-5.3%) |
| Sept 2002 | - | $2.28 M(+1.7%) | $8.78 M(+4.5%) |
| June 2002 | - | $2.24 M(+4.5%) | $8.41 M(+8.0%) |
| Mar 2002 | - | $2.15 M(+1.2%) | $7.79 M(+9.1%) |
| Dec 2001 | $8.69 M(+2.7%) | $2.12 M(+11.3%) | $7.14 M(-11.0%) |
| Sept 2001 | - | $1.90 M(+17.5%) | $8.02 M(-0.5%) |
| June 2001 | - | $1.62 M(+8.3%) | $8.06 M(-2.0%) |
| Mar 2001 | - | $1.50 M(-50.1%) | $8.23 M(-2.8%) |
| Dec 2000 | $8.46 M(+26.9%) | $3.00 M(+54.5%) | $8.47 M(+7.4%) |
| Sept 2000 | - | $1.94 M(+8.9%) | $7.88 M(+4.5%) |
| June 2000 | - | $1.78 M(+2.9%) | $7.54 M(+5.4%) |
| Mar 2000 | - | $1.73 M(-28.2%) | $7.15 M(+4.1%) |
| Dec 1999 | $6.67 M(+81.7%) | $2.42 M(+50.8%) | $6.87 M(+26.7%) |
| Sept 1999 | - | $1.60 M(+14.3%) | $5.42 M(+19.9%) |
| June 1999 | - | $1.40 M(-3.3%) | $4.52 M(+24.9%) |
| Mar 1999 | - | $1.45 M(+49.5%) | $3.62 M(-52.8%) |
| Dec 1998 | $3.67 M(+307.8%) | $970.00 K(+38.6%) | $7.67 M(-253.4%) |
| Sept 1998 | - | $700.00 K(+40.0%) | -$5.00 M(+614.3%) |
| June 1998 | - | $500.00 K(-90.9%) | -$700.00 K(-124.1%) |
| Mar 1998 | - | $5.50 M(-147.0%) | $2.90 M(+480.0%) |
| Dec 1997 | $900.00 K(-280.0%) | -$11.70 M(-334.0%) | $500.00 K(-92.4%) |
| Sept 1997 | - | $5.00 M(+22.0%) | $6.60 M(+88.6%) |
| June 1997 | - | $4.10 M(+32.3%) | $3.50 M(+288.9%) |
| Mar 1997 | - | $3.10 M(-155.4%) | $900.00 K(-228.6%) |
| Dec 1996 | -$500.00 K(-68.8%) | -$5.60 M(-394.7%) | -$700.00 K(-83.7%) |
| Sept 1996 | - | $1.90 M(+26.7%) | -$4.30 M(+16.2%) |
| June 1996 | - | $1.50 M(0.0%) | -$3.70 M(+32.1%) |
| Mar 1996 | - | $1.50 M(-116.3%) | -$2.80 M(+55.6%) |
| Dec 1995 | -$1.60 M(-36.0%) | -$9.20 M(-468.0%) | -$1.80 M(-124.3%) |
| Sept 1995 | - | $2.50 M(+4.2%) | $7.40 M(+12.1%) |
| June 1995 | - | $2.40 M(-4.0%) | $6.60 M(+11.9%) |
| Mar 1995 | - | $2.50 M(+47.1%) | $5.90 M(-395.0%) |
| Dec 1994 | -$2.50 M(-37.5%) | - | - |
| Aug 1994 | - | $1.70 M(0.0%) | -$2.00 M(-35.5%) |
| May 1994 | - | $1.70 M(-128.3%) | -$3.10 M(-26.2%) |
| Feb 1994 | - | -$6.00 M(-1100.0%) | -$4.20 M(-333.3%) |
| Feb 1994 | -$4.00 M | - | - |
| Nov 1993 | - | $600.00 K(0.0%) | $1.80 M(+50.0%) |
| Aug 1993 | - | $600.00 K(0.0%) | $1.20 M(+100.0%) |
| May 1993 | - | $600.00 K | $600.00 K |
FAQ
- What is Trinity Biotech annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Trinity Biotech?
- What is Trinity Biotech annual EBITDA year-on-year change?
- What is Trinity Biotech quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Trinity Biotech?
- What is Trinity Biotech quarterly EBITDA year-on-year change?
- What is Trinity Biotech TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Trinity Biotech?
- What is Trinity Biotech TTM EBITDA year-on-year change?
What is Trinity Biotech annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TRIB is -$24.10 M
What is the all time high annual EBITDA for Trinity Biotech?
Trinity Biotech all-time high annual earnings before interest, taxes, depreciation & amortization is $64.67 M
What is Trinity Biotech annual EBITDA year-on-year change?
Over the past year, TRIB annual earnings before interest, taxes, depreciation & amortization has changed by -$9.91 M (-69.80%)
What is Trinity Biotech quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TRIB is -$1.11 M
What is the all time high quarterly EBITDA for Trinity Biotech?
Trinity Biotech all-time high quarterly earnings before interest, taxes, depreciation & amortization is $50.84 M
What is Trinity Biotech quarterly EBITDA year-on-year change?
Over the past year, TRIB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.77 M (+71.35%)
What is Trinity Biotech TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TRIB is -$8.37 M
What is the all time high TTM EBITDA for Trinity Biotech?
Trinity Biotech all-time high TTM earnings before interest, taxes, depreciation & amortization is $62.51 M
What is Trinity Biotech TTM EBITDA year-on-year change?
Over the past year, TRIB TTM earnings before interest, taxes, depreciation & amortization has changed by +$33.69 M (+80.10%)